Junichi Tomomatsu
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer-related Molecular Pathways
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 3
- Inflammatory Biomarkers in Disease Prognosis 3
- Peptidase Inhibition and Analysis 3
-
- Sarcoma Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Shunji Takahashi (41 shared papers)Kenji Nakano (34 shared papers)Makiko Ono (27 shared papers)Naoki Fukuda (25 shared papers)Yasuyoshi Sato (23 shared papers)Tetsuya Urasaki (26 shared papers)Akihiro Ohmoto (20 shared papers)Xiaofei Wang (19 shared papers)
- Journals
- Annals of Oncology (5 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Management and Research (2 papers)Cancer Science (2 papers)Anticancer Research (2 papers)
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
Junichi Tomomatsu
46 papers receiving 443 citations
Peers
Comparison fields: 5 of 51
- Otorhinolaryngology 54
- Oncology 171
- Endocrinology, Diabetes and Metabolism 57
- Pulmonary and Respiratory Medicine 105
- Genetics 34
Countries citing papers authored by Junichi Tomomatsu
This map shows the geographic impact of Junichi Tomomatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Tomomatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Tomomatsu more than expected).
Fields of papers citing papers by Junichi Tomomatsu
This network shows the impact of papers produced by Junichi Tomomatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Tomomatsu. The network helps show where Junichi Tomomatsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junichi Tomomatsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2020 | 28 | |
| 3 | 2021 | 21 | |
| 4 | 2018 | 21 | |
| 5 | 2020 | 21 | |
| 6 | 2021 | 20 | |
| 7 | 2017 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 2016 | 19 | |
| 10 | 2021 | 16 | |
| 11 | 2010 | 16 | |
| 12 | 2021 | 14 | |
| 13 | 2016 | 14 | |
| 14 | 2020 | 12 | |
| 15 | 2015 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2016 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2015 | 10 | |
| 20 | 2021 | 8 |
About Junichi Tomomatsu
Junichi Tomomatsu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 49 papers that have together received 450 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (10 papers), Sarcoma Diagnosis and Treatment (9 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Otorhinolaryngology (54 citations), Oncology (171 citations), Endocrinology, Diabetes and Metabolism (57 citations), Pulmonary and Respiratory Medicine (105 citations) and Genetics (34 citations). Junichi Tomomatsu has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Shunji Takahashi, Kenji Nakano, Makiko Ono, Naoki Fukuda, Yasuyoshi Sato, Tetsuya Urasaki, Akihiro Ohmoto, Xiaofei Wang, Hiroki Mitani and Mayu Yunokawa. Their work appears in journals such as Annals of Oncology, Cancer Chemotherapy and Pharmacology, Cancer Management and Research, Cancer Science and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.